Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? (Q53619470)

16 May 2018

title

Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? (English)

1 reference

16 May 2018

1 reference

1 reference

Uri Ladabaum

1 reference

16 May 2018

Kenneth Song

series ordinal

1 reference

16 May 2018

A Mark Fendrick

series ordinal

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

16 May 2018

Clinical Gastroenterology and Hepatology

published in

1 reference

16 May 2018

volume

1 reference

16 May 2018

issue

1 reference

16 May 2018

page(s)

554-563

1 reference

16 May 2018

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Clinical practice. Screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Colorectal cancer screening: clinical guidelines and rationale

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Virtual colonoscopy--what it can do vs what it will do.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

An evidence-based medicine approach to economic studies: assessing the cost-effectiveness of competing strategies for colorectal cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Polyps and cancer of the large bowel: a necropsy study in Liverpool

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

The prevalence of polyps of the large intestine in Oslo: an autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

INCIDENCE AND DISTRIBUTION OF ADENOMATOUS POLYPS OF THE COLON AND RECTUM BASED ON 1,000 AUTOPSY EXAMINATIONS

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Adenomatous lesions of the large bowel:An autopsy survey

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

A Comparison of Virtual and Conventional Colonoscopy for the Detection of Colorectal Polyps

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Optimization of CT colonography technique: prospective trial in 180 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Colorectal neoplasms: prospective comparison of thin-section low-dose multi-detector row CT colonography and conventional colonoscopy for detection.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Computerized tomographic colonography: performance evaluation in a retrospective multicenter setting1 1Vital Images Inc. has supported research at UCLA (to D. S. K. L., J. A. B., and E. G. M.). Monex provided support (to M. M.). GE Medical Systems pr

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

CT colonography of colorectal polyps: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Cost-effectiveness of screening for colorectal cancer in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Cost-effectiveness model for colon cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Cost-effectiveness of colonoscopy in screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Colon cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Patient experience and preferences toward colon cancer screening: a comparison of virtual colonoscopy and conventional colonoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Acceptance by patients of multidetector CT colonography compared with barium enema examinations, flexible sigmoidoscopy, and colonoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

Feasibility of colonoscopy screening: discussion of issues and recommendations regarding implementation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900247-2

7 January 2021

10.1016/S1542-3565(04)00247-2

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018